DOC Updates

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals.

Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.

This issue will review:

1. Management and Outcomes of Severe Hypoglycemia Treated by Emergency Medical Services in the U.S. Upper Midwest T2DM
2. Diabetes Microvascular Disease Diagnosis and Treatment After High-Deductible Health Plan Enrollment
3. Historic Residential Redlining and Present-day Diabetes Mortality and Years of Life Lost: The Persistence of Structural Racism
4. Model for Integration of Monogenic Diabetes Diagnosis Into Routine Care: The Personalized Diabetes Medicine Program
5. Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes
6. Dietary Protein Sources, Mediating Biomarkers, and Incidence of Type 2 Diabetes: Findings From the Women's Health Initiative and the U.K. Biobank

For more information about each of ADA's science and medical journals, please visit www.diabetesjournals.org.

Presented by:

Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Chair-Department of Family Medicine, Abington Jefferson Health

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals.

Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.

This issue will review:

1. Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association T2DM
2. Early and ongoing stable glycaemic control is associated with a reduction in major adverse cardiovascular events in people with type 2 diabetes
3. Effect of Deintensifying Diabetes Medications on Negative Events in Older Veteran Nursing Home Residents
4. Changes in Arterial Stiffness and Heart Rate Variability in Youth-Onset Type 1 Versus Type 2 Diabetes
5. Tirzepatide Once Weekly for the Treatment of Obesity
6. Diabetes Remission in the Alliance of Randomized Trials of Medicine Versus Metabolic Surgery in Type 2 Diabetes

For more information about each of ADA's science and medical journals, please visit www.diabetesjournals.org.

Presented by:

Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Chair-Department of Family Medicine, Abington Jefferson Health

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals.

Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.

This issue will review:

1. Risks and burdens of incident diabetes after Covid-19
2. Trends in Timing of and Glycemia at Initiation of Second-line treatment for T2DM
3. Safety of Empagliflozin in Patients with Type 2 Diabetes and CKD
4. Weight Change During Postintervention Follow-up of the Look AHEAD Study

1. Progression to Diabetes Among Older Adults With Prediabetes
2. Association between DM and gray matter atrophy patterns in Older Adults

For more information about each of ADA's science and medical journals, please visitwww.diabetesjournals.org.

Presented by:

Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Chair-Department of Family Medicine, Abington Jefferson Health

In this special three-part series we will be doing a deep dive into diabetic peripheral neuropathy. In this third episode Drs. J. Robinson Singleton and Robin Marcus join our host, Dr. Neil Skolnik to discuss non-pharmacologic treatment of diabetic peripheral neuropathy. In part 1 we covered the epidemiology, pathophysiology, clinical manifestations, screening and diagnosis of diabetic peripheral neuropathy and in part 2 of the series we covered pharmacologic management. This series is supported by an unrestricted educational grant to the American Diabetes Association from Nevro, Inc.

Presented by:

Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

Dr. J. Robinson Singleton and Dr. Robin Marcus. Dr. Singleton is Professor and Vice Chair for VA affairs, Neurology, Director, CTSI Clinical Trials Services Foundation at the University of Utah and Chief of Service, Neurology in the Salt Lake City Veterans Administration Health System. For more information about diabetic peripheral neuropathy, please see the full compendium at: professional.diabetes.org/monographs

Dr. Robin Marcus is a Specialist in Orthopedic Physical Therapy in the Department of Physical Therapy and Athletic Training and Professor and Associate Dean for Clinical Affairs in the College of Health at the University of Utah.

In this special episode on continuous glucose monitoring (CGM) and time in range Dr. Halis Kaan Akturk joins our host, Dr. Neil Skolnik to new technology for CGM and its promises for people with diabetes. This special episode is supported by an independent educational grant from Abbot.

Presented by:

Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

Dr. Halis Kaan Akturk. Dr.Akturk is an Assistant Professor of Medicine and Pediatrics at the University of Colorado, Barbara Davis Center for Diabetes and the Communications Director of American Diabetes Association, Diabetes Technology Interest Group.

For more information about CGM and Time in Range, please go to: www.professional.diabetes.org/timeinrange

Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.

This issue will review:

1. The Incidence of Diabetes Among 2,777,768 Veterans With and Without Recent SARS-CoV-2 Infection
2. Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes
3. Persistence of Risk for Type 2 Diabetes After Gestational Diabetes
4. Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO- DKD Study
5. Use of Lipid-, Blood Pressure–, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
6. Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes The SURPASS-5 Trial

For more information about each of ADA's science and medical journals, please visit www.diabetesjournals.org.

Presented by:

Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Chair-Department of Family Medicine, Abington Jefferson Health

In this special three-part series we will be doing a deep dive into diabetic peripheral neuropathy. In this second episode Dr. Rodica Pop-Busui joins our host, Dr. Neil Skolnik to discuss pharmacologic treatment of diabetic peripheral neuropathy. In part 1 we covered the epidemiology, pathophysiology, clinical manifestations, screening and diagnosis of diabetic peripheral neuropathy and in part 3 of the series we will cover non-pharmacologic management. This series is supported by an unrestricted educational grant to the American Diabetes Association from Nevro, Inc.

Presented by:

Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

Dr. Rodica Pop-Busui MD, PhD. Dr. Pop-Busui is the Larry D. Soderquist Professor in Diabetes, Professor of Internal Medicine Metabolism, Endocrinology and Diabetes, Vice Chair of Clinical Research, Department of Internal Medicine, Director, Clinical Research, Mentoring and Development, Caswell Diabetes Institute, Co-Director JDRF Center of Excellence at the University of Michigan

For more information about diabetic peripheral neuropathy, please see the full compendium at:professional.diabetes.org/monographs

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals.

Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.

This issue will review:

1. The carbohydrate-insulin model
2. Continuous Glucose Monitoring Initiation Within First Year of Type 1 Diabetes Diagnosis Is Associated With Improved Glycemic Outcomes
3. Type 2 diabetes, glycemic control and its association with dementia and its major sub types
4. Real-world evidence of efficacy and safety of SGLT-2 inhibitors as adjunctive therapy in adults with type 1 diabetes
5. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes
6. Cost-Related Medication Nonadherence in Adults With Diabetes in the United States

For more information about each of ADA's science and medical journals, please visitwww.diabetesjournals.org.

Presented by:

Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Chair-Department of Family Medicine, Abington Jefferson Health

In this special episode on continuous glucose monitoring (CGM) and time in range Dr. Dr. Nicole Ehrhardt joins our host, Dr. Neil Skolnik to discuss potential benefits of CGM use and time in range prior to and during pregnancy for women who have diabetes.

Presented by:

Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

Nicole Ehrhardt, M.D., Assistant Professor in the Department of Medicine, Division of Endocrinology and Nutrition, University of Washington.

For more information about CGM and Time in Range, please go to: www.professional.diabetes.org/timeinrange